In Finland, market access for hospital drugs and medical technologies isnβt just about regulatory approval, itβs about PALKO.
The Finnish Council for Choices in Health Care (Palveluvalikoimaneuvosto, PALKO) acts as a critical gatekeeper [β¦]
Thank you to everyone who made this yearβs ISPE such a rewarding event.
Highlights from the Quantify team:
π§ Emilie and Kirkβs session on extending inference from randomised clinical trials (RCTs) to the real world showcased several approaches in external control arms [β¦]
Our colleagues Kirk Geale, PhD and Emilie Toresson Grip are still on site in Washington.
πDonβt miss your chance to connect! Book a meeting to say hello before the conference wraps up.
Β
π§ Β ZoΓ« obtained her bachelorβs degree in neuroscience from Cardiff University / Prifysgol Caerdydd and masterβs degree in neuroimaging from UCL, followed by a masterβs degree in public health [β¦]
πββοΈYesterday a strong team from Quantify participated in convinistafetten in Stockholm. Well done everyone and thanks to Mathias Lilja for the support!
Good luck to everyone running today!
The 41st annual meeting at International Society for Pharmacoepidemiology is approaching. We are pleased to announce our attendance and participation in the upcoming program at the Walter E. Washington Convention Center, Washington DC, USA. [β¦]
We are excited to welcome Isabella Sundelin to the Quantify Research team as our new HR Generalist.
Isabella has a Bachelor of Science in Personnel, Work and Organization from Stockholm University. She began her career in recruitment and has spent the [β¦]
Excited to share that our Danish-Swedish real-world study has been selected for the ππππ πππ¬π π¨π πππππππ slide deck β highlighting it as one of this yearβs top abstracts.
The abstract, co-authored by Jonas Banefelt and Mathias Lilja, explores the link [β¦]
Quantify Research is part of the program this year in Barcelona:
-Kelsi Smith (Quantify Research) presents poster P628 on βSex differences in the association of the melanocortin-1 receptor (MC1R) [β¦]
See what else will change below π
The DMP has published updated requirements for the single technology assessment (STA) submission process, applying to both reimbursement and hospital medicines, effective from 1 September 2025.
Key changes:
β’ π Companies must notify the DMP of [β¦]